Clinical trial · Interventional
BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS
BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS ON METFORMIN THERAPY IN A WEST AFRICA SUB-REGION
NCT02505516CI-TRIAL-00018605completedEarly Phase 1ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
patients om metformin from diabetic clinic were checked for bladder cancer
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
| Diabetes | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| metformin | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- PLACEBO_COMPARATOR
- label
- metformin
- description
- metformin 500mg
- interventionNames
- Other: metformin
- type
- NO_INTERVENTION
- label
- not on metformin
Primary outcomes (1)
- measure
- Number of diabetic patients on metformin therapy
- timeFrame
- 6 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 25 Years
- Maximum age
- 86 Years
Show eligibility criteria text
Inclusion Criteria: * 150 people attending diabetic clinic Exclusion Criteria:
References
Publications (0)
Data not yet available
No reference posted for this study.